NLRP3-IN-10 is a potent Significantly reduced IL-1β release in the spleen of mice after 6 h treatment.
Significantly reduced the increase of peritoneal neutrophil influx compared with the control group.
[1]. Zhang R, et al. New Highly Potent NLRP3 Inhibitors: Furanochalcone Velutone F Analogues. ACS Med Chem Lett. 2022 Mar 7;13(4):560-569.
















